A Study Evaluating Efficacy and Safety of VX-548 for Acute Pain After a Bunionectomy
Completed · Phase 2 · Has a placebo group
Conditions studied: Acute Pain
In brief
The purpose of this study is to evaluate the efficacy and safety of VX-548 doses in treating acute pain after a bunionectomy.
Key facts
- Study ID
- NCT04977336
- Run by
- Vertex Pharmaceuticals Incorporated
- People needed
- 274
- Starts
- 2021-07-19
- Expected to finish
- 2022-03-04
- Last updated by the study team
- 2025-06-25
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Shoals Medical Trials Inc. — Sheffield, Alabama, United States
- Arizona Research Center — Phoenix, Arizona, United States
- Anaheim Clinical Trials — Anaheim, California, United States
- Lotus Clinical Research — Pasadena, California, United States
- New Hope Research Development — Tarzana, California, United States
- Atlanta Center for Medical Research — Atlanta, Georgia, United States
- Chesapeake Research Group — Pasadena, Maryland, United States
- Midwest Clinical Research Center — Dayton, Ohio, United States
- First Surgical Hospital — Bellaire, Texas, United States
- Legent Orthopedic Hospital — Carrollton, Texas, United States
- Endeavor Clinical Trials — San Antonio, Texas, United States
- JBR Clinical Research — Salt Lake City, Utah, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.